Amerigroup Corporation, a managed healthcare company, has reached a comprehensive settlement agreement in principle that will conclude its civil qui tam litigation relating to certain marketing practices of its former Illinois health plan.

In 2007, the court had entered a judgment against the company and its Illinois subsidiary of approximately $334 million, plus the fees of the relator’s counsel. Under the terms of the proposed settlement, the company will pay $225 million to the US and the state of Illinois, plus approximately $9 million in legal fees, and will not admit any wrongdoing.

Additionally, the company will enter into a corporate integrity agreement with the Office of the Inspector General of the US Department of Health and Human Services. The agreement in principle is subject to definitive settlement documentation by the parties.

Amerigroup will report a one-time charge for the settlement of approximately $199 million net of the estimated tax benefit, in the second quarter ended June 30, 2008. The company will pay the settlement from restricted funds previously established to cover costs related to the judgment.

Following the payment, which is expected to occur during the third quarter of 2008, the company’s unrestricted cash balance will increase by approximately $117 million due to the release of excess restricted funds. These funds will be available for general corporate purposes. The company will also be favorably impacted by estimated tax benefits of approximately $35 million.

James Carlson, chairman and CEO of Amerigroup, said: We are concluding this litigation now to remove a source of significant legal and financial uncertainty for our organization. With this matter resolved, we can concentrate fully on the business at hand – meeting the healthcare needs of our members and continuing to serve our government partners.